Unlocking the Therapeutic Potential of Minor Cannabinoids
About the webinar
Learning Outcomes
- Identify the unique therapeutic properties of minor cannabinoids like CBG, CBC, and CBN, and how they differ from major cannabinoids like THC and CBD.
- Evaluate the potential clinical applications of minor cannabinoids in treating various health conditions, supported by current research and case studies.
- Integrate minor cannabinoids into clinical practice effectively, understanding dosing strategies, potential interactions, and patient considerations.
About the speaker

Dr Bonni Goldstein, the Medical Director of Canna-Centers Wellness & Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions, brings a wealth of knowledge and expertise in the field of medicinal cannabis and its applications in treating various conditions.
After years of working in Pediatric Emergency medicine and witnessing the beneficial effects of medical cannabis in an ill friend, she developed a keen interest in the science of medical cannabis.
Over the last 15 years, she has evaluated thousands of patients for the use of medical cannabis and has a special interest in treating children with intractable epilepsy, autism, cancer, and other conditions. Her latest book, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain”, was published in September 2020.
Claim 1 CPD Hour

Related content
Live Webinar02 Dec 2026, 07:00 PMBeyond the Dose: Understanding Oral Cannabinoid Therapy
Explore how formulation, absorption and metabolism influence the bioavailability and clinical effects of oral THC and CBD. This webinar examines key pharmacokinetic principles, emerging delivery technologies and published evidence to inform formulation selection, dosing and patient monitoring.
Learn more
On-demand WebinarPastilles in Clinical Practice: Optimising Precision Dosing, Adherence and Patient Outcomes
Explore the clinical role of cannabis pastilles, including precision dosing, patient selection, adherence, safety and the evolving evidence for major and minor cannabinoids.
Learn more
On-demand WebinarEmerging Therapeutics for Behavioural and Psychological Symptoms of Dementia
Explore evidence-based management of behavioural and psychological symptoms of dementia and the emerging role of cannabinoid-based medicines.
Learn more
On-demand WebinarTHCV and Metabolic Health: Exploring the Evidence and Clinical Potential
Explore the emerging role of Δ9-tetrahydrocannabivarin (THCV) in metabolic health, including its potential influence on appetite regulation, glucose metabolism and weight management. This session reviews THCV pharmacology, CB1 signalling, current preclinical and human evidence, and the key limitations shaping its potential future clinical application.
Learn more

.png)
